Parkes Lab

Parkes Lab Oxford Institute of Radiation Oncology. Cancer Immunology research, innate immune pathways, working towards better science = better cancer treatment

[Monica Olcina @olcina_mm]

Excited to share the first @olcina_lab preprint where we describe how C5aR1 regulates cancer cell fate and can be targeted to improve radiotherapy even in tumours with immunosuppressive features. https://t.co/01Jx0p6fp4 #bioRxiv

Many thanks to @olcina_lab and collaborators!

[Jamie Kwon @JKwonCTaeWook]

Thrilled to have had the opportunity to represent @ParkesLab and present my work at the DNA-damage response in cell physiology and disease workshop in Sounio. An incredible venue with amazing science and even better people. #EMBODNAdamage

[Matt Bottomley @bottomleymatt]

@eileen_parkes from @ParkesLab modifies the concept of Swiss cheese models to highlight all the constituent parts that need to come together for an effective tumour response - love this concept #OIS2022

[Segun Afolaranmi @OJAfolaranmi]

😊😊 Thank you so much Eileen @eileen_parkes. Grateful for your immense support. If anyone’s interested in Tumor immunology/DNA damage, I highly recommend the @ParkesLab. Super smart and supportive people!

[Parkes Lab @ParkesLab]

Jamie is a brilliant student, supported by @ProstateUK working together with @LabBryant on modelling and treating DNA repair deficient prostate cancer

[Parkes Lab @ParkesLab]

The very first Parkes lab publication is online! Congratulations to DPhil student @OxfordOncology @OIRO Jamie Kwon - read about the tumour microenvironment of #Prostate cancer and ideas for future immunogenomic subtyping 👇https://t.co/gSuWhxBTV0

[Prostate Cancer UK @ProstateUK]

.@eileen_parkes is a researcher.

You helped us save research like Dr Parkes' by raising almost £2m to keep work going in lockdown.

But we can't stop now. The end of the pandemic may be in sight, but prostate cancer is as big a threat as ever.

Donate ➡️ https://t.co/VVrkliw7rA

[Parkes Lab @ParkesLab]

Lab in lockdown has been a challenge - now greeting the new academic year and welcoming wonderful DPhil students :) Feeling a bit daunted but excited!

[Parkes Lab @ParkesLab]

Thank you @ImmunoSW for a warm welcome and the opportunity to share our work! Been a long term admirer of the world class immunologists in Cardiff and great to have the opportunity to interact

[BSI South Wales @ImmunoSW]

Looking forward to an exciting talk by @eileen_parkes hosed by @DrAnnAger. Welcome @CUBLSResearch @DCGseminars @CUSystemsImmu

[Oxford Cancer @OxfordCancer]

We talk to @sharib_m from @bdi_oxford in our new blog about the challenges in the early detection of oesophageal cancer

Sharib is improving the accuracy of endoscopic diagnosis through the use of AI technologies and global AI collaborations

Read more👇
https://t.co/F1CuGHjPU9

[BSI Tumour Immunology @BSI_TumourImm]

The first #CheckpointInhibition review explores #TIGIT as a novel checkpoint. From structural biology and expression, to mechanism and the clinical potential of TIGIT inhibition.
Thanks Dr Harjunpää & Dr @CGuillerey!
👉 https://t.co/MrCNsom3iK

@CEIjournal
#immunotherapy
#cancer

[UK CORONAVIRUS CANCER PROJECT @UKCORONACANCER]

Visual summary of first UK coronavirus cancer data.

[Kathy Gately @kathygately1]

Great keynote talk on #STING signalling by Dr Eileen Parkes @ParkesLab @TCDTMI conference 2020

[Salma Kaochar @Kaochar2]

Very thoughtful and valuable thoughts! Thank you @rosslevinemd

[@[email protected] @bpfairfax]

1. https://t.co/Sn3LBklW6c New work from the group describing transcriptomic analysis of CD8 responses to immune checkpoint blockade in melanoma. We find genes encoding TCR are over-expressed in samples from melanoma patients who proceed to have a sustained response to treatment

[Prostate Cancer Foundation @PCFnews]

If you're looking for who to thank for this viral @BillNye moment... on behalf of @PCFnews, we'd like to say: "You're welcome." 🙃 #BlueJacketFashionShow @tbjfashionshow

[Parkes Lab @ParkesLab]

Definitely agree with meeting-free weeks - learning to protect your time is such a key skill (I'm still learning!) https://t.co/9s6xh03ngT

[Parkes Lab @ParkesLab]

Such a privilege to interview prospective PhD candidates over the past few days - so impressed to see everyone passionate about tackling cancer - the future of cancer research is in good hands!

[Elizabeth McKenna @ElizSMcKenna]

@CD_AACR starting off 2020 strong with the first-in-human trial of A2AR blockade for #immunotherapy, the first report of a clinical #KRAS G12C inhibitor (first online during #Targets19), content from @LabMassague, @derlabunc, @michele_teng, @Samuel_Bakhoum, and more!

[OxfordOncology @OxfordOncology]

Fancy an alternative #AdventCalendar...? Check out our science themed #CountdownToChristmas

What's behind door number one?
👉https://t.co/yzlSsmfWMW

#STEMadvent #CancerResearch #DNA #Hypoxia